These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1838050)

  • 21. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
    Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
    Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a vacuum tumescence device in the management of impotence in men with a history of penile implant or severe pelvic disease.
    Korenman SG; Viosca SP
    J Am Geriatr Soc; 1992 Jan; 40(1):61-4. PubMed ID: 1727850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
    Bell DS; Cutter GR; Hayne VB; Lloyd LK
    Urology; 1992 Jul; 40(1):36-40. PubMed ID: 1621310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.
    Saenz de Tejada I; Goldstein I; Azadzoi K; Krane RJ; Cohen RA
    N Engl J Med; 1989 Apr; 320(16):1025-30. PubMed ID: 2927481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing.
    Allen RP; Brendler CB
    J Urol; 1988 Sep; 140(3):518-22. PubMed ID: 3411665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
    Soderdahl DW; Thrasher JB; Hansberry KL
    Br J Urol; 1997 Jun; 79(6):952-7. PubMed ID: 9202565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An exploration of central dysregulation of erectile function as a contributing cause of diabetic impotence.
    Nofzinger EA; Schmidt HS
    J Nerv Ment Dis; 1990 Feb; 178(2):90-5. PubMed ID: 2299340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penile corporeal fibrosis complicating papaverine self-injection therapy for erectile impotence.
    Desai KM; Gingell JC
    Eur Urol; 1988; 15(1-2):132-3. PubMed ID: 3215228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection.
    Lue TF; Mueller SC; Jow YR; Hwang TI
    Urol Clin North Am; 1989 Nov; 16(4):799-807. PubMed ID: 2683308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vacuum constriction devices: second-line conservative treatment for impotence.
    Gilbert HW; Gingell JC
    Br J Urol; 1992 Jul; 70(1):81-3. PubMed ID: 1638379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined sildenafil with vacuum erection device therapy in the management of diabetic men with erectile dysfunction after failure of first-line sildenafil monotherapy.
    Sun L; Peng FL; Yu ZL; Liu CL; Chen J
    Int J Urol; 2014 Dec; 21(12):1263-7. PubMed ID: 25039272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suction device therapy in the management of erectile impotence.
    Witherington R
    Urol Clin North Am; 1988 Feb; 15(1):123-8. PubMed ID: 3344556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes.
    Parfitt VJ; Wong R; Dobbie A; Hartog M; Gingell JC
    Diabet Med; 1992 Dec; 9(10):947-9. PubMed ID: 1478042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is intracavernous injection of papaverine a reliable screening test for vascular impotence?
    Buvat J; Buvat-Herbaut M; Dehaene JL; Lemaire A
    J Urol; 1986 Mar; 135(3):476-8. PubMed ID: 3944889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadal dysfunction in diabetic men with organic impotence.
    Murray FT; Wyss HU; Thomas RG; Spevack M; Glaros AG
    J Clin Endocrinol Metab; 1987 Jul; 65(1):127-35. PubMed ID: 3584393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction.
    Baltaci S; Aydos K; Kosar A; Anafarta K
    Br J Urol; 1995 Dec; 76(6):757-60. PubMed ID: 8535721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vacuum constriction device for management of erectile impotence.
    Witherington R
    J Urol; 1989 Feb; 141(2):320-2. PubMed ID: 2913353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.